Publications

Search our bibliography using the filters on the right-hand side.

Displaying 251 through 300 of 387 publications.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Incidence of diabetic maculopathy among patients with diabetic retinopathy. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic macular edema in type II diabetes in UK primary care. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272-3.

Tse (Kawai) A, Tseng HF, Greene SK, Vellozzi C, Weintraub E, McCarthy N. Risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):365-6.

Gastanaga VM, Bui C, Gutierrez L, Taylor A, Kelsh MA. Epidemiology of metastatic pancreatic cancer in the United States and selected European countries. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Supp 3):S469-70.

Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiol Drug Saf. 2012 Jul 1;21(7):697-709.

Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Response to commentary by Marcus and Gibbons. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):713.

Rowan CG, Brunelli SM, Munson J, Flory J, Reese PP, Hennessy S, Lewis J, Mines D, Barrett JS, Bilker W, Strom BL. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2012 May;21(5):494-506. doi: 10.1002/pds.3199

Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012 May 1;21(Suppl. 2):69-80.

Kauf TL, Davis KL, Earnshaw SR, Davis EA. Spillover adherence effects of fixed-dose combination HIV therapy. Patient Prefer Adherence. 2012 Feb 1;6:155-64.

Nkohma E, Zhao Y, Esposito D, Mines D, Holick C. Patterns of medication use during pregnancy and prevalence of birth defects in a large administrative claims database. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):390.

Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. Optimal approaches to one-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Supp 3):S34-5.

Sturkenboom M, Fourrier-Reglat A, Perez-Gutthann S, Garbe E, Nicotra F, Romio S. How to conduct collaborative studies in the EU? Lessons and results from the completed Safety of NSAIDs (SOS) Project. Pharmacoepidemiol Drug Saf. 2012;21(suppl 3):S38-9.

Vandenberghe F, Choong E, Saigi-Morgui N, Quteineh L, Ambresin AE, von Gunten A, Conus P, Eap CB. Clinical study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population. Poster presented at the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):456. doi: 10.1002

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011 Dec 1;20(12):1225-36.

Kilpatrick RD, Danese MD, Belozeroff V, Smirnakis K, Goodman WG, Rothman KJ. The association of vitamin d use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case–crossover study. Pharmacoepidemiol Drug Saf. 2011 Sep 1;20(9):914-21.

Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay L, Riera Guardia N, Saltus CW, Quinlan S, Holick CN, Wahl PM, Rothman KJ, Wallander MA, Perez-Gutthann S. Case screening and validation in a population-based study of antimicrobial use and acute liver injury. Presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 14, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 12; 20(S1):S5-6. doi: 10.1002/pds.2206

Lanes SF, Rothman KJ. Back to the future: time loops in defining study populations. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S311.

Castellsague J, Pisa F, Rosolen V, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Use of nimesulide, other nsaids and the risk of upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Analysis of cases with codes with high positive predictive value. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S178.

Mikkelsen EM, Riis AH, Hatch EE, Rothman KJ, Wise LA, Sorensen HT. Use of nsaids and other mild analgesics and time to pregnancy. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S55.

Huybrechts KF, Seeger JD, Glynn R, Rothman KJ, Avorn J, Lii J, Schneeweiss S. Accounting for regional variations in medical practice in comparative effectiveness studies. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl. 1):S325.

Yong M, Schenfeld J, Creamer K, Shi Y, Aras G, Anthony MS. External comparator data for the observational post-marketing safety surveillance registry of enbrel® (etanercept) for the treatment of psoriasis – a single-arm registry study. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S228.

Johannes C, Andrews E, McQuay L, Frohlich M, Sims R. Incidence of cerebrovascular accidents in men with prostate cancer. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 18, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S271-2.

Rubino A, Wallander MA, Callreus T, Saddier P, Ritchey ME, Perez-Gutthann S. Drug utilization studies and risk management plans: a missing link. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 1; 20(Suppl. 1):S269.

Pisa F, Drigo D, Riera-Guardia N, Castellsague J, Rosolen V, Clagnan E, Tosolini F, Zanier L, Perez-Gutthann S, Barbone F. Validation of primary and secondary ICD-9-cm codes for upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 1, 2011. [abstract] Pharmacoepidemiol Drug Saf. 20(Suppl. 1):S172.

Wyss R, Stedman MR, Brookhart MA, Rothman KJ, Glynn R, Poole C, Seeger JD, Sturmer T. Balance of controlled and uncontrolled covariates as a function of propensity score variable selection methods: a simulation study. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S350.

Midkiff KD, Harris D, Gilsenan AW, Wu Y, Andrews EB. Drug safety studies using cancer registry data: confluence of elements impacting the interview response rate. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 14, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 1; 20(Suppl. 1):S231. doi: 10.1002/pds.2206

López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. The pattern of use of anti-depressant drugs in a pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S101.

López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. Adherence to antidepressant treatment among pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S316.

Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Sturmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011 Jun 1;20(6):551-9.

Mines D, Gu Y, Kou TD, Cooper GS. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):111-8. doi: 10.1002/pds.2057

Johannes CB, Varas-Lorenzo C, McQuay L, Midkiff KD, Fife D. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010 Sep 1;19(9):881-8.

Riera Guardia N, Castellsague J, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F. The SOS Project: nonsteroidal anti-inflammatory drugs and upper gastrointestinal complications: meta-analysis of epidemiological studies. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, UK. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug 24; 19(Suppl 1):S314.

Arana A, Wentworth CE, Rivero E, Plana E, Conde E. Lymphoma among patients with atopic dermatitis treated with topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCIs). Poster presented at the 26th International Conference on Pharmacoepidemiology; August 2010. Brighton, England. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S12.

Gilsenan A, Andrews E, Hollis KA. Characterization of current risk evaluation and mitigation strategies. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S100. doi: 10.1002/pds.2019

Tennis P, Rothman KJ, Bohn R, Tan H, Anthony MS, Zavras A, Calingaert B. Multiple myeloma and IV bisphosphonate are risk factors for osteonecrosis of the jaw. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S313-4.

Huang K, Gutierrez LP, Bulow S, Gallinger S, Castells A, Eagle CJ, Church JM. Clinical outcomes in familial adenomatous polyposis (FAP) patients with a long-term treatment of celecoxib: a matched cohort study. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S:61.

Gilsenan AW, Andrews EB, Midkiff KD, Ladner A. Charting a new course in long-term safety: the critical role of cancer registries. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S116.

Martín-Merino M, Fortuny J, Plana E, Rivero E, García-Rodríguez LA. Incidence of diabetic retinopathy and diabetic macular edema in newly diagnosed type I and type 2 diabetic patients. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S251-2.

López-León S, Fortuny J, Plana E, Rivero E. The pattern of use of anti-depressant drugs. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(1):S289.

Mines D. Invited editorial. Commentary on the validation studies of sudden cardiac death and ventricular arrhythmia by Hennessy et al. and Chung et al. Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):573-5. doi: 10.1002/pds.1913.

Goldberg JF, McLeod LD, Fehnel SE, Williams VSL, Hamm LR, Gilchrist K. Development and psychometric evaluation of the Bipolar Functional Status Questionnaire (BFSQ). Bipolar Disord. 2010 Feb 1;12(1):32-44.

Varas-Lorenzo C, Castellsaque J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1016-25.

Andrews EB, Colvin L, Hernández-Díaz S, Holmes L, Chambers T, Margulis A, Mitchell A. Evaluating study designs for the measurement of drug exposure in pregnancy. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S28-9.

Riera-Guardia N, Hirst C, Castellsague J, Varas-Lorenzo C, Pariente A, Sturkenboom MCJM, Perez-Gutthann S. The SOS project: cardiovascular and gastrointestinal safety of NSAIDS. Preliminary results of a systematic review of epidemiological studies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S207.

Acquavella J, Weinhandl E, Bradbury B, Brookhart A, Sturmer T, Rothman KJ. Confounding by indication studying epoetin and mortality. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S28.

Perez-Gutthann S, Sturmer T, Platt R, Strom BL, Saddier P, Raine J. How should we plan and communicate interim results of pharmacoepidemiology studies? An ispe public policy forum. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S123-4.

Saddier P, Perez-Gutthann S, Stem-hagen A, Garg R, Blackburn S, Dal Pan G. Rmp, riskmap and rems: the challenges of epidemiology. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S203-4.

Villa M, Mannino S, Lucchi S, Rothman KJ. Definition of the risk-window for the outcomes of the live study by minimization of the mean squared error (MSE) of the estimator. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S151.

Midkiff KD, Gilsenan AW, Martin RD, Wu Y, Masica D, Andrews EB. The impact of patient access on post marketing drug safety studies using cancer registry data. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 14; 18(Suppl 1):S169. doi: 10.1002/pds.1806

Loughlin J, Quinn S, Rivero E, Norman H, Earnest DL, Wong J, Seeger JD. No evidence for association of tegaserod with suicide-related outcomes. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S154-5.